107 related articles for article (PubMed ID: 17479870)
21. The study on adriamycin induced DNA scissions in human cells with different activity of some antioxidant enzymes.
Chłopkiewicz B; Gruber B
Acta Pol Pharm; 2000; 57(5):359-62. PubMed ID: 11126026
[TBL] [Abstract][Full Text] [Related]
22. Changes in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells.
Tsimokha AS; Mittenberg AG; Kulichkova VA; Kozhukharova IV; Gause LN; Konstantinova IM
Cell Biol Int; 2007 Apr; 31(4):338-48. PubMed ID: 17346995
[TBL] [Abstract][Full Text] [Related]
23. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action and spectrum of cell types susceptible to doxorubicin photochemotherapy.
Gao JP; Lanks KW; Rosen M; Lai BT
Cancer Chemother Pharmacol; 1997; 40(2):138-42. PubMed ID: 9182835
[TBL] [Abstract][Full Text] [Related]
25. Time-targeted therapy (TTT): proof of principle using doxorubicin and radiation in a cultured cell system.
Zhang Y; Williams JR
Acta Oncol; 2007; 46(5):621-7. PubMed ID: 17562438
[TBL] [Abstract][Full Text] [Related]
26. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
27. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
Wang JX; Li Q; Li PF
Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
[TBL] [Abstract][Full Text] [Related]
29. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker.
Lavignac N; Nicholls JL; Ferruti P; Duncan R
Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501
[TBL] [Abstract][Full Text] [Related]
30. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
31. De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
Rath G; Schneider C; Langlois B; Sartelet H; Morjani H; Btaouri HE; Dedieu S; Martiny L
Int J Biochem Cell Biol; 2009 May; 41(5):1165-72. PubMed ID: 19027085
[TBL] [Abstract][Full Text] [Related]
32. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
33. Effect of doxorubicin on actin reorganization in Chinese hamster ovary cells.
Grzanka D; Domaniewski J; Grzanka A
Neoplasma; 2005; 52(1):46-51. PubMed ID: 15739026
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells.
Kik K; Wasowska-Lukawska M; Oszczapowicz I; Szmigiero L
Anticancer Res; 2009 Apr; 29(4):1429-33. PubMed ID: 19414398
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
36. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
[TBL] [Abstract][Full Text] [Related]
37. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.
Lee SY; Kim JW; Jeong MH; An JH; Jang SM; Song KH; Choi KH
FEBS Lett; 2008 Aug; 582(19):2826-32. PubMed ID: 18656471
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin.
Beillerot A; Domínguez JC; Kirsch G; Bagrel D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1102-5. PubMed ID: 18164200
[TBL] [Abstract][Full Text] [Related]
39. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
40. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines.
Rogalska A; Koceva-Chyła A; Jóźwiak Z
Chem Biol Interact; 2008 Oct; 176(1):58-70. PubMed ID: 18692031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
